Inceptor Bio Revenue and Competitors
Estimated Revenue & Valuation
- Inceptor Bio's estimated annual revenue is currently $7.5M per year.
- Inceptor Bio's estimated revenue per employee is $108,696
Employee Data
- Inceptor Bio has 69 Employees.
- Inceptor Bio grew their employee count by 50% last year.
Inceptor Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15M | 67 | 29% | N/A | N/A |
#2 | $5203.7M | 27951 | 5% | N/A | N/A |
#3 | $3.6M | 7 | -61% | N/A | N/A |
#4 | $0.9M | 10 | 25% | N/A | N/A |
#5 | $1.6M | 23 | 0% | N/A | N/A |
#6 | $2.3M | 37 | 0% | N/A | N/A |
#7 | $1.9M | 26 | 4% | N/A | N/A |
#8 | $3.7M | 22 | 16% | N/A | N/A |
#9 | $1.7M | 22 | 5% | N/A | N/A |
#10 | N/A | 11 | 267% | N/A | N/A |
What Is Inceptor Bio?
Inceptor Bio is developing multiple next-generation cell therapy platforms to cure difficult-to-treat cancers with a focus on novel mechanisms to enhance immune cell performance in the tumor microenvironment. To achieve this goal, we assembled a purpose-driven team, recruiting pioneers in oncology, gene therapy, cell therapy and gene editing to join our mission. We provide a unique partnership model to university research programs focused on cutting-edge therapeutic approaches for oncology. The combination of our lab and manufacturing resources with the industry experience of our cell and gene therapy experts will advance therapeutics into the clinic with remarkable efficiency.
keywords:N/AN/A
Total Funding
69
Number of Employees
$7.5M
Revenue (est)
50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $24.7M | 69 | -1% | N/A |
#2 | $25.4M | 69 | 0% | N/A |
#3 | $24.8M | 69 | -3% | N/A |
#4 | $11.4M | 69 | 5% | N/A |
#5 | $29.5M | 69 | 17% | N/A |